Apyx Medical Corporation (APYX) Increased to $8.11 on Mar, 19

Apyx Medical Corporation (NASDAQ:APYX) rose considerably to $8.11. Barchart.com announced it on Mar, 19. The company has $276.05M market cap. $8.28M more could be NASDAQ:APYX valuation at $8.35 share price.

For more Apyx Medical Corporation (NASDAQ:APYX) news posted briefly go to: Nasdaq.com, Seekingalpha.com, Nasdaq.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “The Bull is Big Data – Nasdaq” posted on March 18, 2019, “VIPS, CAR, DLPH and ATTU among notable midday movers – Seeking Alpha” on February 21, 2019, “Conatus’ (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus – Nasdaq” with a publish date: March 11, 2019, “EA’s Shooter Looter Game Anthem Disappoints, Hurts Stock – Nasdaq” and the last “China stocks drop on Brexit worries, trade deal caution – Nasdaq” with publication date: March 13, 2019.

Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide.The firm is worth $276.05 million. The firm markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market.4.2 is the P/E ratio. The Company’s Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.